Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Rizzo

Showing results (621-630 of 693) with videos related to

Pageof 70
Sort By:
The American Journal of Managed Care|November 10, 2009
Effectiveness of care coordination and health counseling in advancing illnessJoseph B Engelhardt, Victoria M Rizzo, Richard D Della Penna, et al.
Glycobiology|November 1, 2011
Antitumor effects of hyaluronic acid inhibitor 4-methylumbelliferone in an orthotopic hepatocellular carcinoma model in miceFlavia Piccioni, Mariana Malvicini, Mariana G Garcia, et al.
European Journal of Human Genetics : EJHG|September 19, 2013
Two ABCB4 point mutations of strategic NBD-motifs do not prevent protein targeting to the plasma membrane but promote MDR3 dysfunctionDario Degiorgio, Paola A Corsetto, Angela M Rizzo, et al.
World Journal of Urology|July 11, 2019
Preclinical study for treatment of hypospadias by advanced therapy medicinal productsV Sceberras, E Attico, E Bianchi, et al.
European Cardiology|July 3, 2020
Tolerability Profile and Discontinuation Causes of Sacubitril/Valsartan Treatment in 'Real-life' Patients with Heart Failure and Reduced Ejection FractionM Rizzo, I Colomer-Asenjo, G Cabello-Molina, et al.
Current Cancer Drug Targets|April 3, 2012
High CXCR4 expression correlates with sunitinib poor response in metastatic renal cancerC D' Alterio, L Portella, A Ottaiano, et al.
Frontiers in Public Health|January 30, 2023
Evolution and expansion of the One Health approach to promote sustainable and resilient health and well-being: A call to actionElizabeth L Mumford, Deniss J Martinez, Karli Tyance-Hassell, et al.
Cancer Immunology, Immunotherapy : CII|April 20, 2023
Phenotypic and functional analysis in HER2+ targeted therapy of human NK cell subpopulation according to the expression of FcεRIγ and NKG2C in breast cancer patientsMaría B Bordignon, Ayelén I Pesce Viglietti, Estefanía P Juliá, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 20, 2015
Sunitinib administered on 2/1 schedule in patients with metastatic renal cell carcinoma: the RAINBOW analysisS Bracarda, R Iacovelli, L Boni, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 29, 2015
Sunitinib administered on 2/1 schedule in patients with metastatic renal cell carcinoma: the RAINBOW analysisS Bracarda, R Iacovelli, L Boni, et al.
Pageof 70

Showing results (621-630 of 693) with videos related to

Sort By:
Pageof 70
The American Journal of Managed Care|November 10, 2009
Effectiveness of care coordination and health counseling in advancing illnessJoseph B Engelhardt, Victoria M Rizzo, Richard D Della Penna, et al.
Glycobiology|November 1, 2011
Antitumor effects of hyaluronic acid inhibitor 4-methylumbelliferone in an orthotopic hepatocellular carcinoma model in miceFlavia Piccioni, Mariana Malvicini, Mariana G Garcia, et al.
European Journal of Human Genetics : EJHG|September 19, 2013
Two ABCB4 point mutations of strategic NBD-motifs do not prevent protein targeting to the plasma membrane but promote MDR3 dysfunctionDario Degiorgio, Paola A Corsetto, Angela M Rizzo, et al.
World Journal of Urology|July 11, 2019
Preclinical study for treatment of hypospadias by advanced therapy medicinal productsV Sceberras, E Attico, E Bianchi, et al.
European Cardiology|July 3, 2020
Tolerability Profile and Discontinuation Causes of Sacubitril/Valsartan Treatment in 'Real-life' Patients with Heart Failure and Reduced Ejection FractionM Rizzo, I Colomer-Asenjo, G Cabello-Molina, et al.
Current Cancer Drug Targets|April 3, 2012
High CXCR4 expression correlates with sunitinib poor response in metastatic renal cancerC D' Alterio, L Portella, A Ottaiano, et al.
Frontiers in Public Health|January 30, 2023
Evolution and expansion of the One Health approach to promote sustainable and resilient health and well-being: A call to actionElizabeth L Mumford, Deniss J Martinez, Karli Tyance-Hassell, et al.
Cancer Immunology, Immunotherapy : CII|April 20, 2023
Phenotypic and functional analysis in HER2+ targeted therapy of human NK cell subpopulation according to the expression of FcεRIγ and NKG2C in breast cancer patientsMaría B Bordignon, Ayelén I Pesce Viglietti, Estefanía P Juliá, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 20, 2015
Sunitinib administered on 2/1 schedule in patients with metastatic renal cell carcinoma: the RAINBOW analysisS Bracarda, R Iacovelli, L Boni, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 29, 2015
Sunitinib administered on 2/1 schedule in patients with metastatic renal cell carcinoma: the RAINBOW analysisS Bracarda, R Iacovelli, L Boni, et al.
Pageof 70